Ramipril and Iga nephropathy - a phase IV clinical study of FDA data

Summary:

Iga nephropathy is reported as a side effect among people who take Ramipril (ramipril), especially for people who are male, 60+ old, also take Amlodipine, and have Hypertonic bladder.

The phase IV clinical study analyzes which people have Iga nephropathy when taking Ramipril. It is created by eHealthMe based on reports of 144,209 people who have side effects when taking Ramipril from the FDA, and is updated regularly.

What is Ramipril?

Ramipril has active ingredients of ramipril. It is often used in high blood pressure. eHealthMe is studying from 147,398 Ramipril users. Check the latest studies of Ramipril.

What is Iga nephropathy?

Iga nephropathy (kidney disease- condition prevents the kidneys from filtering waste) is found to be associated with 90 drugs and 424 conditions by eHealthMe. Check the latest studies of Iga nephropathy.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

144,209 people reported to have side effects when taking Ramipril.
Among them, 19 people (0.01%) have Iga nephropathy.

Among these 19 people:

What is the gender of people who have Iga nephropathy when taking Ramipril? *

female: 23.53 %
male: 76.47 %

What is the age of people who have Iga nephropathy when taking Ramipril? *

What are other drugs people take besides Ramipril? *

What are other side effects people have besides Iga nephropathy? *

Renal Impairment (severely reduced kidney function): 6 people, 31.58%
Nephrotic Syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema): 6 people, 31.58%
Weakness: 3 people, 15.79%
Lymphoma (cancer that begins in immune system cells): 3 people, 15.79%
Disease Progression: 3 people, 15.79%
Drug Ineffective: 3 people, 15.79%
Dyslipidaemia (abnormal amount of lipids): 3 people, 15.79%
Dyspnea (difficult or laboured breathing): 3 people, 15.79%
Fatigue (feeling of tiredness): 3 people, 15.79%
Generalised Oedema (swelling all over the body): 3 people, 15.79%

What are the existing conditions these people have? *

Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 3 people, 15.79%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 10.53%
Prostatic Disorder: 1 person, 5.26%
Interstitial Nephritis (inflammation of the kidney): 1 person, 5.26%
Infection: 1 person, 5.26%
Glomerulonephritis (a group of conditions that affect parts of the kidneys called glomeruli): 1 person, 5.26%
Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Ramipril and have Iga nephropathy?

- Check whether Iga nephropathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ramipril:

Ramipril (147,398 reports)

Iga nephropathy treatments and more:

Iga nephropathy (5,130 reports)

Browse all side effects of Ramipril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Iga nephropathy:

Iga nephropathy (90 drugs)

Browse all the conditions that are associated with Iga nephropathy:

Iga nephropathy (424 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ramipril (the active ingredients of Ramipril) and Ramipril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.